Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
Primary Purpose
Bipolar Disorder
Status
Completed
Phase
Phase 1
Locations
Australia
Study Type
Interventional
Intervention
Transcranial direct current stimulation (Eldith DC Stimulator)
Sponsored by
About this trial
This is an interventional basic science trial for Bipolar Disorder
Eligibility Criteria
Inclusion Criteria:
- Participants will be right-handed subjects aged 18-65 meeting DSM-IV diagnostic criteria for bipolar disorder, with no acute episodes of depression or mania within the previous 12 weeks
- A score of ≤ 20 on the MADRS, and a score of ≤ 6 on the YMRS, who have been on a stable dose of mood stabiliser medications for at least 1 month.
Exclusion Criteria:
- Patients with high suicide risk
- Co-morbid DSM-IV diagnosis of any psychotic disorder (current or within the last year), schizophrenia and schizoaffective disorder
- Mental retardation
- A history of drug or alcohol abuse or dependence within the last 3 months
- Co-morbid attention deficit hyperactivity disorder (ADHD), or any neurological disorder
- Recent stroke
- Head injury
- History of seizure, or who have had electroconvulsive therapy (ECT) within the 6 months preceding enrolment.
- Participants will also be excluded if currently taking medications known to be associated with frank cognitive impairment (e.g., benzodiazepines).
Sites / Locations
- University of New South Wales
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Sham Comparator
Active Comparator
Active Comparator
Arm Label
Sham transcranial direct current stimulation
Transcranial direct current stimulation
Different transcranial direct current stimulation montage
Arm Description
Outcomes
Primary Outcome Measures
Total correct responses.
Total number of correct responses on each task in each session.
Secondary Outcome Measures
Full Information
NCT ID
NCT01339598
First Posted
April 7, 2011
Last Updated
November 2, 2015
Sponsor
The University of New South Wales
1. Study Identification
Unique Protocol Identification Number
NCT01339598
Brief Title
Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
Study Type
Interventional
2. Study Status
Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
October 2015 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
The University of New South Wales
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study aims to investigate the potential for Transcranial Direct Current Stimulation (tDCS) to enhance cognitive functioning in euthymic bipolar patients through comparing the effect of active or sham tDCS (placebo control) during the performance of two cognitive tasks. The investigators hypothesize that task performance will be improved with active relative to sham tDCS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Disorder
7. Study Design
Primary Purpose
Basic Science
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sham transcranial direct current stimulation
Arm Type
Sham Comparator
Arm Title
Transcranial direct current stimulation
Arm Type
Active Comparator
Arm Title
Different transcranial direct current stimulation montage
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation (Eldith DC Stimulator)
Intervention Description
Eldith DC Stimulator (NeuroConn GmbH, Germany)
Primary Outcome Measure Information:
Title
Total correct responses.
Description
Total number of correct responses on each task in each session.
Time Frame
Across each session (approximately 1 hour in duration), with each session conducted at least 1 week apart.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants will be right-handed subjects aged 18-65 meeting DSM-IV diagnostic criteria for bipolar disorder, with no acute episodes of depression or mania within the previous 12 weeks
A score of ≤ 20 on the MADRS, and a score of ≤ 6 on the YMRS, who have been on a stable dose of mood stabiliser medications for at least 1 month.
Exclusion Criteria:
Patients with high suicide risk
Co-morbid DSM-IV diagnosis of any psychotic disorder (current or within the last year), schizophrenia and schizoaffective disorder
Mental retardation
A history of drug or alcohol abuse or dependence within the last 3 months
Co-morbid attention deficit hyperactivity disorder (ADHD), or any neurological disorder
Recent stroke
Head injury
History of seizure, or who have had electroconvulsive therapy (ECT) within the 6 months preceding enrolment.
Participants will also be excluded if currently taking medications known to be associated with frank cognitive impairment (e.g., benzodiazepines).
Facility Information:
Facility Name
University of New South Wales
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2031
Country
Australia
12. IPD Sharing Statement
Learn more about this trial
Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
We'll reach out to this number within 24 hrs